Skip to main content
. 2019 Mar 20;20(6):1397. doi: 10.3390/ijms20061397
ADC Antibody-drug conjugate
ALL Acute lymphoblastic leukemia
AML Acute myeloid leukemia
BCR B-cell receptor
bsAB Bispecific antibody
CAR Chimeric antigen receptor
CLL Chronic lymphocytic leukemia
CML Chronic myeloid leukemia
DC Dendritic cell
FLT3 FMS-like tyrosine kinase-3
HLA Human leukocyte antigen
hTERT Human telomerase reverse transcriptase
ITD Internal tandem duplication
LAA Leukemia-associated antigen
LC-MS/MS Liquid chromatography-coupled tandem mass spectrometry
mAB Monoclonal antibody
MDS Myelodysplastic syndrome
NPM1 Nucleophosmin
PRAME Preferentially expressed antigen of melanoma
PD-1 Programmed death-1
PD-L1 Programmed death-ligand 1
RHAMM Receptor for hyaluronan-mediated motility
TCR T-cell receptor
TLR Toll-like receptor
TKI Tyrosine kinase inhibitor
WT1 Wilms’ tumor gene